The healing arts program at Winship Cancer Institute of Emory University at Emory Johns Creek Hospital (EJCH) is helping patients in their fight against cancer.
The "oncometabolite" D-2-hydroxyglutarate, produced by some brain tumors, can be detected by mass spectrometry in cerebrospinal fluid.
The Bone Marrow and Stem Cell Transplant Center at Winship Cancer Institute of Emory University in Atlanta is celebrating its 5,000th patient receiving a bone marrow or stem cell transplant.
Emory University's Chemical Biology Discovery Center has been selected as a Specialized Center in the Chemical Biology Consortium, a national network of scientists on the leading edge of drug discovery and development, centered at the Frederick National Laboratory for Cancer Research.
Emory Saint Joseph's Hospital is offering a minimally invasive radio embolization treatment called the Y-90, for patients with primary or metastatic liver cancer.
Rally Foundation for Childhood Cancer Research has awarded a $50,000 Rally for Research Grant to Emory School of Medicine to support Dr. Renee Read and her research on brain cancer therapies.
More than three thousand walkers and runners are expected to lace up their sneakers and raise money for cancer research on Saturday, October 1st at the sixth annual Winship Win the Fight 5K.
The fourth Winship Cancer Institute Gala is being called the most successful fundraising event in Emory University's history, raising more than $1.3 million dollars. The proceeds will benefit cancer research at Winship.
A new clinical study by Winship Cancer Institute of Emory University seeks to increase the number of women at hereditary risk for breast and ovarian cancer who are seen for genetic counseling services.
Emory Winship cancer biologist Xingming Deng, MD, PhD and his lab have identified two novel agents which could reverse the resistance of cancer cells to treatment.